Physician profile
Michael Gallina
NPI 1841279486
$882.61
in general payments reported to CMS, 2019-2025
22 companies · $253 in 2025
The $253 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $38.81 · 2022: $53.76 · 2023: $132 · 2024: $118 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $169.45 | 2019-2025 | Mako |
| Bioventus LLC | $92.41 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Amgen INC. | $60.14 | 2019-2024 | Krystexxa |
| Treace Medical Concepts, INC. | $53.77 | 2025 | |
| Pfizer INC. | $51.18 | 2019 | |
| Paratek Pharmaceuticals, INC. | $47.16 | 2022-2025 | Nuzyra |
| Coastal Medical Technologies LLC | $45.08 | 2024 | |
| Janssen Biotech, INC. | $41.30 | 2019 | |
| Horizon Therapeutics Plc | $40.31 | 2023 | Krystexxa |
| Biocomposites INC | $37.69 | 2025 | Stimulan |
| Solventum Corporation | $37.12 | 2025 | Prevena |
| Ucb, INC. | $28.22 | 2019-2020 | |
| Vericel Corporation | $25.63 | 2025 | Maci |
| Phathom Pharmaceuticals, INC. | $22.84 | 2024 | Voquezna |
| Depuy Synthes Sales INC. | $22.10 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.65 | 2023 | |
| Ibsa Pharma INC. | $19.25 | 2023 | Tirosint, Licart |
| Ethicon US, LLC | $16.95 | 2022 | |
| Antares Pharma, INC. | $15.13 | 2019 | |
| Radius Health, INC. | $14.69 | 2020 | |
| Orthofix Medical, INC. | $12.69 | 2019 | |
| Fidia Pharma USA INC. | $9.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gallina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.